Binding of Human Blood-coagulation Factors IXa and X to Phospholipid Membranes

Overview

Journal Biochem J

Specialty Biochemistry

Date 1984 Nov 1

PMID 6334516

Citations 17

Authors

K Mertens

R Cupers

A van Wijngaarden

R M Bertina

Affiliations

Soon will be listed here.

Abstract

A simple centrifugation technique has been developed to study the interaction of human coagulation Factors IXa and X with phospholipid membranes. In the presence of Ca2+, equimolar phosphatidylserine/phosphatidylcholine membranes form tight complexes with Factor X (KD = 2.8 X 10(-8) M); the KD is independent of the phospholipid concentration. Binding sites are available for about 2 mmol of Factor X/mol of phospholipid. Factor IXa has a slightly higher affinity for the phospholipid membrane (KD = 1.2 X 10(-8)M), and competes with Factor X for binding. The experimentally observed competition between Factor X and Factor IXa is in agreement with a model that describes the binding of two distinct ligands to a single class of independent binding sites.

Citing Articles

Coagulation factor VIII: biological basis of emerging hemophilia A therapies.

Samelson-Jones B, Doshi B, George L Blood. 2024; 144(21):2185-2197.

PMID: 39088776 PMC: 11600081. DOI: 10.1182/blood.2023023275.

Phosphatidylserine Regulation of Coagulation Proteins Factor IXa and Factor VIIIa.

Majumder R J Membr Biol. 2022; 255(6):733-737.

PMID: 36098799 DOI: 10.1007/s00232-022-00265-7.

SAXS analysis of the intrinsic tenase complex bound to a lipid nanodisc highlights intermolecular contacts between factors VIIIa/IXa.

Childers K, Peters S, Lollar P, Spencer H, Doering C, Spiegel P Blood Adv. 2022; 6(11):3240-3254.

PMID: 35255502 PMC: 9198903. DOI: 10.1182/bloodadvances.2021005874.

Haemophilia.

Berntorp E, Fischer K, Hart D, Mancuso M, Stephensen D, Shapiro A Nat Rev Dis Primers. 2021; 7(1):45.

PMID: 34168126 DOI: 10.1038/s41572-021-00278-x.

A factor VIIIa-mimetic bispecific antibody, Mim8, ameliorates bleeding upon severe vascular challenge in hemophilia A mice.

Ostergaard H, Lund J, Greisen P, Kjellev S, Henriksen A, Lorenzen N Blood. 2021; 138(14):1258-1268.

PMID: 34077951 PMC: 8499050. DOI: 10.1182/blood.2020010331.

References

Bender M, BEGUE-CANTON M, Blakeley R, Brubacher L, Feder J, GUNTER C . The determination of the concentration of hydrolytic enzyme solutions: alpha-chymotrypsin, trypsin, papain, elastase, subtilisin, and acetylcholinesterase. J Am Chem Soc. 1966; 88(24):5890-913. DOI: 10.1021/ja00976a034. View

Mertens K, Bertina R . The contribution of Ca2+ and phospholipids to the activation of human blood-coagulation Factor X by activated Factor IX. Biochem J. 1984; 223(3):607-15. PMC: 1144343. DOI: 10.1042/bj2230607. View

Shapiro S, WAUGH D . The purification of human prothrombin. Thromb Diath Haemorrh. 1966; 16(3):468-90. View

Smith R . Titration of activated bovine Factor X. J Biol Chem. 1973; 248(7):2418-23. View

Papahadjopoulos D, Vail W, Jacobson K, Poste G . Cochleate lipid cylinders: formation by fusion of unilamellar lipid vesicles. Biochim Biophys Acta. 1975; 394(3):483-91. DOI: 10.1016/0005-2736(75)90299-0. View

Chong C, Colbow K . Light scattering and turbidity measurements on lipid vesicles. Biochim Biophys Acta. 1976; 436(2):260-82. DOI: 10.1016/0005-2736(76)90192-9. View

Kisiel W, Hermodson M, Davie E . Factor X activating enzyme from Russell's viper venom: isolation and characterization. Biochemistry. 1976; 15(22):4901-6. DOI: 10.1021/bi00667a023. View

Di Scipio R, Hermodson M, Yates S, Davie E . A comparison of human prothrombin, factor IX (Christmas factor), factor X (Stuart factor), and protein S. Biochemistry. 1977; 16(4):698-706. DOI: 10.1021/bi00623a022. View

Bertina R, Van der Linden I . Inhibitor-neutralisation assay and electro-immuno assay of human factor IX (Christmas factor). Clin Chim Acta. 1977; 77(3):275-86. DOI: 10.1016/0009-8981(77)90230-3. View

10.

Stenflo J, Suttie J . Vitamin K-dependent formation of gamma-carboxyglutamic acid. Annu Rev Biochem. 1977; 46:157-72. DOI: 10.1146/annurev.bi.46.070177.001105. View

11.

Nelsestuen G, Lim T . Equilibria involved in prothrombin- and blood-clotting factor X-membrane binding. Biochemistry. 1977; 16(19):4164-71. DOI: 10.1021/bi00638a005. View

12.

Nelsestuen G, Broderius M . Interaction of prothrombin and blood-clotting factor X with membranes of varying composition. Biochemistry. 1977; 16(19):4172-7. DOI: 10.1021/bi00638a006. View

13.

Day E, Ho J, Kunze Jr R, Sun S . Dynamic light scattering study of calcium-induced fusion in phospholipid vesicles. Biochim Biophys Acta. 1977; 470(3):503-8. DOI: 10.1016/0005-2736(77)90142-0. View

14.

LINDQUIST P, Fujikawa K, Davie E . Activation of bovine factor IX (Christmas factor) by factor XIa (activated plasma thromboplastin antecedent) and a protease from Russell's viper venom. J Biol Chem. 1978; 253(6):1902-9. View

15.

Nelsestuen G, Kisiel W, Di Scipio R . Interaction of vitamin K dependent proteins with membranes. Biochemistry. 1978; 17(11):2134-8. DOI: 10.1021/bi00604a017. View

16.

ZWAAL R . Membrane and lipid involvement in blood coagulation. Biochim Biophys Acta. 1978; 515(2):163-205. DOI: 10.1016/0304-4157(78)90003-5. View

17.

Bertina R, VELTKAMP J . The abnormal factor IX of hemophilia B+ variants. Thromb Haemost. 1978; 40(2):335-49. View

18.

Davie E, Fujikawa K, Kurachi K, Kisiel W . The role of serine proteases in the blood coagulation cascade. Adv Enzymol Relat Areas Mol Biol. 1979; 48:277-318. DOI: 10.1002/9780470122938.ch6. View

19.

Tokutomi S, Eguchi G, OHNISHI S . Disappearance of calcium-induced phase separation in phosphatidylserine-phosphatidylcholine membranes caused by protonation and by electric current. Biochim Biophys Acta. 1979; 552(1):78-88. DOI: 10.1016/0005-2736(79)90247-5. View

20.

Dombrose F, Gitel S, Zawalich K, Jackson C . The association of bovine prothrombin fragment 1 with phospholipid. Quantitative characterization of the Ca2+ ion-mediated binding of prothrombin fragment 1 to phospholipid vesicles and a molecular model for its association with phospholipids. J Biol Chem. 1979; 254(12):5027-40. View